ArticleSurgical endoscopy2020
Robotic extended cholecystectomy in gallbladder cancer.
Article in Surgical endoscopy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Robotic, laparoscopic and open surgery for gallbladder cancer: a systematic review and network meta-analysis.Surgical endoscopy · 2024Pooled it
- Systematic review and meta-analysis of robotic versus laparoscopic radical cholecystectomy for gallbladder cancer.Hepatobiliary surgery and nutrition · 2026Article
- Robotic single-port plus one-port radical cholecystectomy: description of surgical techniques with video.Journal of minimally invasive surgery · 2026Article
- Robotic surgical management of gallbladder cancer: comparing outcomes and feasibility of hepatectomy with or without bile duct resection and reconstruction.Updates in surgery · 2026Article
- Pioneering complex biliary surgeries with the Revo-i robotic surgical system: initial cases of choledochal cyst and gallbladder tumor (with video).Journal of minimally invasive surgery · 2025Article
- Evolution from laparoscopic to robotic radical resection for gallbladder cancer: a propensity score-matched comparative study.Surgical endoscopy · 2025Article
- Exploring the Potential of Robotic Single-Port Surgery for Gallbladder Cancer: Initial Insights and Future Prospects.Annals of surgical oncology · 2025Article
- Evolution of minimally invasive cholecystectomy: a narrative review.BMC surgery · 2024Review
- Application of laparoscopic surgery in gallbladder carcinoma.World journal of clinical cases · 2023Review
- The technique of laparoscopic and robotic extended cholecystectomy for gallbladder cancer.Journal of minimally invasive surgery · 2023Article
- Treatment of Resectable Gallbladder Cancer.Cancers · 2022Review
- Robotic Surgery for Biliary Tract Cancer.Cancers · 2022Review
- Essential updates 2019/2020: Surgical treatment of gallbladder cancer.Annals of gastroenterological surgery · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe application of minimally invasive surgery (MIS) in advanced gallbladder cancer (GBC) requiring extended cholecystectomy is challenging, in terms of achieving clinically safe and complete oncologic resection. Recently developed robotic systems, however, may provide advantages in overcoming difficulties faced by laparoscopic MIS. The purpose of this study is to investigate the feasibility and advantages of a robotic system to assist with extended cholecystectomy.
methodsPatients diagnosed with clinically suspected stage T2 or above, GBC (as determined by preoperative computed tomography or ultrasonography) underwent robotic extended cholecystectomy (REC) from February 2018 to January 2020. The attached video shows the detailed procedure in the following order: the positioning of the patient and the trocars, Kocher maneuver, lymph node dissection (#8, 9, 12, 13), skeletonization of hepatoduodenal ligament, ligation of the cystic duct and liver resection.
resultsOf 16 patients who underwent REC, mean operation time was 198.3 min and the median estimated blood loss was 295 ml. 11 patients (68.8%) were pathologically diagnosed as stage T2 or above, and the metastatic lymph node was identified in 3 patients (18.8%). All cases had secured tumor-free resection margins, and 3 patients (18.8%) showed invasion to the hepatic parenchyma. The mean number of retrieved lymph nodes was 7.2. The median duration of hospital stay was 7 days. There were no mortality or recurrence within 90 days after the operation.
conclusionThis study suggests that robotic systems can be safely utilized in advanced stage GBC, facilitating oncologically sufficient lymph node dissection and rapid recovery.
Indexed as
Identifiers
32306112What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.